ClinicalTrials.Veeva

Menu

Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM (SPIRIT-HCM)

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Completed

Conditions

Hypertrophic Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Investigators aim to assess changes in exercise capacity and quality of life after septal myectomy in patient with hypertrophic cardiomyopathy.

Full description

The objective of this study is to examine change in quality of life and functional capacity as respectively measured by, Quality of Life Questionnaires and six-minute walk test distance, following septal myectomy in patients with obstructive hypertrophic cardiomyopathy, as compared to prior to surgery.

Enrollment

177 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled to undergo septal myectomy.
  • Established diagnosis of obstructive HCM defined as:

LVH Thickness ≥15mm left ventricular outflow tract gradient ≥50mmHg

Exclusion criteria

  • Prior septal myectomy or alcohol septal ablation
  • Prior myocardial infarction
  • Uncontrolled arrhythmias including ventricular tachycardia and atrial fibrillation
  • Uncontrolled hypertension
  • Angiographically documented coronary stenosis >50%, if available at time of screening
  • Inability to provide informed consent
  • Inability to walk without assistive devices
  • Peripheral artery disease with claudication

Trial design

177 participants in 2 patient groups

No functional capacity testing
Description:
6 minute walk Quality of life Questionaire
Functional Capacity Testing
Description:
6 minute walk Quality of Life Questionnaire Metabolic stress test

Trial contacts and locations

1

Loading...

Central trial contact

Albree Tower-Rader, MD; Milind Desai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems